From gene therapy cuts to HIV tests, the key FDA moves this week.

November 19, 2025

1. After patient deaths, FDA to trim gene therapy's approval Full story

2. Pfizer to sell $508M stake in BioNTech Full story

3. Prevention > treatment: See how UW Health and others are making precision medicine pay off here.

 

4. FDA approves 1st biosimilar to breast cancer drug Perjeta Full story

5. FDA opens new approval route for personalized treatments Full story

 

6. 2026 will test every clinical leader — how UPMC, Kaiser + others are preparing here.

7. Ozempic, Wegovy to be sold at $199 a month for new patients Full story

8. FDA approves 1-minute HIV self-test Full story

Becker's Learning Opportunities

9. CoxHealth turned virtual care into a 'collaborative engine' across 6 hospitals. See the model here.

10. Clinicians want clear IUD pain protocols. Evidence-based strategies you can use today here.

11. How Providence, WVU Medicine + others are tackling capital pressure and capacity strain: here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication